We are live on ! Find out more
Pathstone Holdings

Pathstone Holdings Portfolio holdings

AUM $34.3B
1-Year Est. Return 27.35%
This Fund
S&P 500
This Quarter Est. Return
-0.94%
1 Year Est. Return
+27.35%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25.1B
AUM Growth
-$790M
Cap. Flow
-$57.8M
Cap. Flow %
-0.23%
Top 10 Hldgs %
30.34%
Holding
2,333
New
109
Increased
1,071
Reduced
889
Closed
111

Sector Composition

Rank Sector Weight
1 Miscellaneous 50.45%
2 Technology 14.93%
3 Financials 8.06%
4 Consumer Discretionary 5%
5 Industrials 4.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RPD icon
2176
Rapid7
RPD
$905M
$66.4K ﹤0.01%
+12,043
New +$111K
IOVA icon
2177
Iovance Biotherapeutics
IOVA
$3.68B
$65.6K ﹤0.01%
18,691
+2,418
+15% +$7.73K
NABL icon
2178
N-able
NABL
$752M
$62.6K ﹤0.01%
+13,407
New +$74.9K
CERT icon
2179
Certara
CERT
$1.29B
$58.1K ﹤0.01%
10,193
-5,513
-35% -$42.1K
BGS icon
2180
B&G Foods
BGS
$283M
$53.5K ﹤0.01%
10,899
-6,120
-36% -$29.6K
TNYA icon
2181
Tenaya Therapeutics
TNYA
$160M
$51.9K ﹤0.01%
75,000
WEST icon
2182
Westrock Coffee
WEST
$786M
$51K ﹤0.01%
12,000
-2,000
-14% -$8.93K
SJT
2183
San Juan Basin Royalty Trust
SJT
$131M
$50.1K ﹤0.01%
10,424
TGEN
2184
Tecogen Inc
TGEN
$96.6M
$47.9K ﹤0.01%
18,725
SEER icon
2185
Seer Inc
SEER
$112M
$47.4K ﹤0.01%
28,205
STIM icon
2186
Neuronetics
STIM
$227M
$46.7K ﹤0.01%
32,231
LXRX icon
2187
Lexicon Pharmaceuticals
LXRX
$1.03B
$46.4K ﹤0.01%
29,774
-195
-0.7% -$284
SABR icon
2188
Sabre
SABR
$872M
$46.3K ﹤0.01%
31,902
+3,808
+14% +$5.07K
ABUS icon
2189
Arbutus Biopharma
ABUS
$1.03B
$45K ﹤0.01%
10,000
THRY icon
2190
Thryv Holdings
THRY
$86.7M
$44.8K ﹤0.01%
+16,366
New +$64.3K
SYM icon
2191
CALL
Symbotic
SYM
$5.37B
$44K ﹤0.01%
+2,000
New +$114K
GLD icon
2192
CALL
SPDR Gold Trust
GLD
$153B
$43.1K ﹤0.01%
+1,000
New +$448K
COTY icon
2193
Coty
COTY
$2.45B
$40.8K ﹤0.01%
20,277
-1,794
-8% -$4.82K
MRVL icon
2194
CALL
Marvell Technology
MRVL
$219B
$38K ﹤0.01%
+1,000
New +$84K
INDI icon
2195
indie Semiconductor
INDI
$828M
$37.6K ﹤0.01%
11,676
-237
-2% -$837
BLND icon
2196
Blend Labs
BLND
$362M
$35.4K ﹤0.01%
20,797
+7,327
+54% +$15.7K
AFCG
2197
AFC Gamma
AFCG
$79.1M
$34.9K ﹤0.01%
+12,385
New +$30.9K
PLTR icon
2198
CALL
Palantir
PLTR
$443B
$32.9K ﹤0.01%
400
OGEN icon
2199
Oragenics
OGEN
$2.36M
$30.8K ﹤0.01%
+55,001
New +$43.5K
CLGN icon
2200
CollPlant Biotechnologies
CLGN
$5.58M
$30.6K ﹤0.01%
57,000
+40,000
+235% +$40.4K

Similar funds

Pathstone Holdings's Q1 2026 Portfolio in Review

As of Q1 2026, Pathstone Holdings held 2,333 positions worth $25.1B, down 3% from $25.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pathstone Holdings's Q1 2026 filing shows 109 new, 1,071 increased, 889 reduced and 111 closed positions. Its largest new stake was FS Credit Opportunities Corp: 2,028,326 shares worth $10.3M. The largest sale was CrowdStrike, an estimated $443M.

By sector, the portfolio is most concentrated in Miscellaneous at 50% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

  • Pathstone Holdings's largest Q1 2026 buy was FS Credit Opportunities Corp: 2,028,326 shares worth $10.3M.
  • Pathstone Holdings added most to Capital Group U.S. Small and Mid Cap ETF in Q1 2026, an estimated $50.6M increase.
  • Pathstone Holdings's biggest Q1 2026 reduction was CrowdStrike, cutting an estimated $443M.
  • Pathstone Holdings fully exited BlackRock Municipal Income Trust II in Q1 2026, selling an estimated $16.9M.
  • Pathstone Holdings's ten largest holdings make up 30% of its $25.1B portfolio in Q1 2026.
  • Pathstone Holdings opened 109 new positions and closed 111 in Q1 2026.
  • Pathstone Holdings's portfolio value fell 3% quarter-over-quarter to $25.1B.

Based on Pathstone Holdings's 13F filing for Q1 2026, filed 11 May 2026.